Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 27, 2012
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - Market Wire
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
[ Mon, Aug 27th 2012
] - WOPRAI
Andrew Peters Downgraded (BMRN) to Hold and Held Target at $45 on, Aug 27th, 2012
Published on 2024-10-25 00:22:03 -
Andrew Peters of Deutsche Bank, Downgraded "BioMarin Pharmaceutical Inc." (BMRN) to Hold and Held Target at $45 on, Aug 27th, 2012.
Andrew has made no other calls on BMRN in the last 4 months.
There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Gena Wang of "Barclays" Initiated at Buy and Held Target at $46 on, Friday, August 24th, 2012
- Matthew Harrison of "Morgan Stanley" Maintained at Strong Buy with Increased Target to $52 on, Monday, July 23rd, 2012
Similar Stocks and Investing Articles
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Mon, Aug 13th 2012
] - WOPRAI
[ Thu, Jul 26th 2012
] - WOPRAI
[ Tue, Jul 24th 2012
] - WOPRAI
[ Mon, Jul 23rd 2012
] - WOPRAI
[ Wed, Jul 18th 2012
] - WOPRAI
[ Fri, Jun 01st 2012
] - WOPRAI
[ Thu, Apr 19th 2012
] - WOPRAI
[ Wed, Apr 11th 2012
] - WOPRAI